Gilead Sciences (GILD) stock in focus as the company joins The Global Fund to expand access to lenacapavir, an HIV PrEP ...

The country has lost out on around R8 billion in funding after the US pulled the plug on what was known as PEPFAR, a ...

Gilead Sciences, Inc. (NASDAQ:GILD) is one of the 10 Best Cheap Stocks to Buy According to Billionaire Ray Dalio.

This isn’t about managing the AIDS pandemic. It’s about ending it — and letting a new generation grow and thrive free of its ...

Gilead announced a deal to get its groundbreaking HIV prevention drug to lower income countries. Notably, the deal does not ...

Gilead Sciences and the Global Fund to Fight AIDS, Tuberculosis and Malaria said on Wednesday they had finalized plans to ...

Several Midwestern Cities have been designated as HIV “hotspots” due to the rising number of new cases; and the South ...

The business mogul, designer and activist will accept the honor in Beverly Hills, Calif., on Sept. 18. The gala, fronted by ...

Millions of lives and decades of progress hang in the balance,” says the president of the International AIDS Society (IAS) ...

Lenacapavir offers twice-yearly HIV prevention with near-complete protection in clinical trials. Clinical trials show ...

Countries in sub-Saharan Africa could see thousands of deaths from HIV due to cuts to the US President’s Emergency Plan for AIDS Relief (PEPFAR), underscoring the necessity of reinstating the program.

Major setbacks in the global fight against HIV may be imminent due to recent funding cuts, public health experts have warned ...